化合物 T10236 T10236

Product Introduction
Bioactivity


英文名: ACHN-975 TFA

描述: ACHN-975 TFA is a selective LpxC inhibitor with a subnanomolar inhibitory. It is against a wide range of gram-negative bacterias with low MIC values (≤1 μg/mL).

动物实验: Animal Model: Neutropenic mouse thigh model with P. aeruginosa ATCC 27853. Dosage: 5-30 mg/kg. Administration: i.p.; single dose [2]

体外活性: ACHN-975 is against Enterobacteriaceae spp, Pa, and Ab with MIC90 values of 1, 0.5, and >64 μg/mL, respectively [1].ACHN-975 is potently against the P. aeruginosa isolates tested, inhibiting 100% of the isolates at a MIC of ≤2?μg/ml. It against Pseudomonas aeruginosa with an MIC50 and MIC90 of 0.06 and 0.25?μg/ml, respectively. ACHN-975 is against six P. aeruginosa isolates, it against P. aeruginosa APAE1064, APAE1232, and APAE1064 isolates with MIC values of 0.12, 0.06, and 0.06 ?μg/ml, respectively [2].

体内活性: ACHN-975 TFA (i.p.; 5-30?mg/kg; single dose) leads to a steady reduction in bacterial titers in the first 4?h following treatment for all dosing groups. The sampling shows that the level of free drug in this model drops below the ACHN-975 MIC for this isolate (0.25?μg/ml) by 2?h after treatment with the 10 mg/kg dose and by 4?h after treatment with the 30 mg/kg dose [2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: ACHN-975 TFA | ACHN975 TFA | ACHN 975 TFA

化合物 T10236 T10236信息由TargetMol中国为您提供，如您想了解更多关于化合物 T10236 T10236报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途